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ffect of Granulocyte-Macrophage
olony-Stimulating Factor Inducer
n Left Ventricular Remodeling
fter Acute Myocardial Infarction
uichiro Maekawa, MD, Toshihisa Anzai, MD, Tsutomu Yoshikawa, MD, Yasuo Sugano, MD,
eitaro Mahara, MD, Takashi Kohno, MD, Toshiyuki Takahashi, MD, Satoshi Ogawa, MD, FACC
okyo, Japan
OBJECTIVES We sought to determine the influence of granulocyte-macrophage colony-stimulating factor
(GM-CSF) induction on post-myocardial infarction (MI) remodeling, especially in relation
to the inflammatory response and myocardial fibrosis.
BACKGROUND Granulocyte-macrophage colony-stimulating factor modifies wound healing by promot-
ing monocytopoiesis and infiltration of monocytes and macrophages into injured tissue;
however, the effect of GM-CSF induction on the infarct healing process and myocardial
fibrosis is unclear.
METHODS A model of MI was produced in Wistar rats by ligation of the left coronary artery. The MI
animals were randomized to receive GM-CSF inducer (romurtide 200 g/kg/day for 7
consecutive days) (MI/Ro) or saline (MI/C).
RESULTS Echocardiographic and hemodynamic studies on day 14 revealed increased left ventricular
(LV) end-diastolic dimension, decreased fractional shortening, elevated LV end-diastolic
pressure, and decreased LV maximum rate of isovolumic pressure development in MI/Ro
compared with MI/C. Immunoblotting showed that expression of transforming growth
factor (TGF)-1 in the infarcted site on day 3 after MI was decreased in MI/Ro
compared with MI/C. In the infarcted site, TGF-1, collagen type I and type III
messenger ribonucleic acid (mRNA) expression on day 3, and collagen content on day 7
were reduced in MI/Ro compared with MI/C, in association with marked infarct
expansion. In MI/Ro, monocyte chemoattractant protein-1 mRNA level and the degree
of infiltration of monocyte-derived macrophages (ED-1-positive) were greater in the
infarcted site on day 7 than those in MI/C.
CONCLUSIONS The GM-CSF induction by romurtide facilitated infarct expansion in association with the
promotion of monocyte recruitment and inappropriate collagen synthesis in the infarcted
region during the early phase of MI. (J Am Coll Cardiol 2004;44:1510–20) © 2004 by the
American College of Cardiology Foundation(
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bongestive heart failure is the most common cause of
ardiac death after myocardial infarction (MI) and develops
uring the process of left ventricular (LV) remodeling,
hich consists of infarct expansion followed by progressive
ilation (1). Defective infarct healing, infarct size, and wall
See page 1521
tress, are major determinants of infarct expansion (2). In
he initial stages of infarct healing, peripheral monocytes
nfiltrate the necrotic myocardium through the up-
egulation of monocyte chemoattractant protein (MCP)-1,
nd they differentiate into macrophages. These monocytes
nd macrophages produce transforming growth factor
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f Medicine, Tokyo, Japan. Supported in part by grants for scientific research
4770333 (Dr. Maekawa) and 14570693 (Dr. Anzai) from the Ministry of Education,
cience, and Culture of Japan.
Manuscript received January 27, 2004; revised manuscript received April 12, 2004,mccepted May 19, 2004.TGF)-1, which is a fibrogenic cytokine related to colla-
en accumulation. Appropriate collagen deposition in the
nfarcted site is necessary to prevent infarct expansion
aused by wall stress. Monocytes and macrophages orches-
rate the infarct healing process through a complex cascade
nvolving cytokines, growth factors, and collagen turnover.
Granulocyte-macrophage colony-stimulating factor
GM-CSF) is a cytokine that stimulates the growth and
ifferentiation of granulocyte and macrophage precursor
ells in vitro (3). The GM-CSF induces peripheral
onocytosis and prolongs the life-span of monocytes via
reduction of apoptosis. It has been reported that
eripheral monocytosis is associated with LV remodeling
fter MI (4). Another study demonstrated that plasma
M-CSF levels were elevated in patients with ischemic
ilated cardiomyopathy and that this increase was asso-
iated with the degree of LV dysfunction (5). Romurtide,
hich is a synthetic muramyldipeptide derivative, has
een known to act as a GM-CSF inducer by binding to
onocytes and macrophages (6,7). The aim of this study
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ost-MI remodeling, especially in relationship to the
nfarct healing process and myocardial fibrosis.
ETHODS
xperimental animals. All experiments were performed in
ccordance with the protocols approved by the Institutional
nimal Care and Use Committee. Male Wistar rats weigh-
ng 250 to 300 g were used. All rats were housed under
dentical conditions and given food and water ad libitum.
xperimental protocol. The rats were anesthetized with
n intraperitoneal injection (IP) of sodium pentobarbital (50
g/kg), intubated, and ventilated with a volume-cycled
mall-animal respirator. The heart was exposed through a
eft thoracotomy, and MI was induced by ligating the left
oronary artery with a prolene 6-0 suture. Rats that died
ithin 24 h after the operation were excluded from the
nalysis. The sham-operated animals underwent the same
rocedure without ligation of the coronary artery and
eceived an IP of saline (Sham) or 200 g/kg/day of
M-CSF inducer (romurtide) for seven days (Sham/Ro).
he MI rats were also treated with saline (MI/C) or a 200
g/kg/day IP of romurtide for seven days (MI/Ro). We
etermined the dosage of romurtide based on results dem-
nstrated by the dosage used to obtain GM-CSF induction
n previous studies. The rats were assigned to four groups
Sham, Sham/Ro, MI/C, and MI/Ro). The investigators
ere blinded regarding sham versus MI and saline versus
omurtide. The heart was excised under an IP of sodium
entobarbital at 3, 7, or 14 days after surgery for each group.
he LV was separated from the atria and the right ventricle,
nd each was weighed, immediately frozen in liquid nitro-
en, and stored at 80°C until use.
emodynamic measurements. On day 14, hemodynamic
arameters were measured in the lightly anesthetized rats
sodium pentobarbital IP). The right carotid artery was
annulated with a Millar ultraminiature catheter (SPR-671,
.4-F, Millar Instruments, Houston, Texas) and advanced
nto the aorta to record arterial pressure. The aortic catheter
as then advanced into the LV to record pressure, the
Abbreviations and Acronyms
ECM  extracellular collagen matrix
GAPDH  glyceraldehyde 3-phosphate dehydrogenase
GM-CSF  granulocyte-macrophage colony-stimulating
factor
LV  left ventricular/ventricle
LVEDD  left ventricular end-diastolic dimension
LVESD  left ventricular end-systolic dimension
MCP  monocyte chemoattractant protein
MI  myocardial infarction
mRNA  messenger ribonucleic acid
PCR  polymerase chain reaction
RWT  relative wall thickness
TGF  transforming growth factoraximum rate of isovolumic pressure development (dP/ ttmax), and the minimum rate of isovolumic pressure decay
dP/dtmin).
chocardiographic study. Transthoracic echocardio-
raphic studies were performed on the lightly anesthetized
ats on day 14 using an echocardiographic system equipped
ith a 12-MHz phased-array transducer (Envisor M2540,
hilips Medical Systems, Andover, Massachusetts).
-mode tracings were recorded through the anterior and
osterior LV walls at the papillary muscle level to measure
eft ventricular end-diastolic dimension (LVEDD), left
entricular end-systolic dimension (LVESD), and LV an-
erior and posterior wall thickness at end-diastole. The LV
ractional shortening and relative wall thickness (RWT)
ere calculated according to the following formulas: LV
ractional shortening  [(LVEDD  LVESD)/LVEDD]
100; RWT  2  posterior wall thickness at
nd-diastole/LVEDD.
nfarct size. After taking the hemodynamic and echocar-
iographic recordings, the LV was fixed by immersion in
0% formalin and embedded in paraffin. Six transverse slices
ere cut from the apex to the base, and serial sections were
ut and mounted. The percentage of infarcted LV was
stimated on day 14 using planimetric techniques (8).
pecimens with a large infarct (40% of the LV free wall)
ere used in this study.
xpansion index. The expansion index was determined on
ay 14 using 10% paraformaldehyde-fixed tissue as previ-
usly described (9). The expansion index was calculated
ith the following formula: expansion index  (LV cavity
rea/total LV area)  (septal thickness/scar thickness).
eripheral leukocyte count. Approximately 1 ml of pe-
ipheral blood was drawn from each rat on days 1, 2, 4, and
for measuring leukocyte counts. The total leukocyte count
as obtained using an improved Neubauer chamber, and
he proportion of monocytes was determined using Giemsa-
tained blood smears.
estern blotting. Frozen tissue was homogenized in buffer
ontaining protease inhibitors in phosphate-buffered saline.
qual amounts of the denatured protein were then analyzed
sing sodium dodecyl sulfate-polyacrylamide gel electrophore-
is. The TGF-1 protein was probed with a rabbit polyclonal
ntibody (1:500 dilution, Santa Cruz Biotechnology Inc.,
anta Cruz, California). Horseradish peroxidase-conjugated
heep anti-rabbit immunoglobulin G (1:5,000 dilution, Roche
olecular Biochemicals, Indianapolis, Indiana) was used as
he secondary antibody. The reaction was developed using
nhanced chemiluminescence reagents (Amersham Bio-
ciences, Piscataway, New Jersey), and an image was obtained
y exposure to X-ray film. Densitometric quantification was
hen performed using Scion image software (Scion Corpora-
ion, Frederick, Maryland). The results were presented as a
ercentage by comparing them with those of an untreated
ontrol, and the control mean was arbitrarily set as 100%.
ibonucleic acid preparation. Total cellular ribonucleic
cid was isolated using a modification of the acid guanidium
hiocyanate and phenol/chloroform extraction method, and
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Effect of GM-CSF Inducer on LV Remodeling October 6, 2004:1510–20sing TRIzol LS Reagent (Life Technologies, Rockville,
aryland) according to the manufacturer’s protocol.
aqMan real-time reverse transcription polymerase
hain reaction analysis. The expression of MCP-1, TGF-
1, collagen type I and type III, GM-CSF, and glyceral-
ehyde 3-phosphate dehydrogenase (GAPDH) messenger
ibonucleic acid (mRNA) was studied using quantitative
eal-time reverse transcription polymerase chain reaction
PCR). The TaqMan probes were labeled with a 5= reporter
ye, 6-carboxyfluorescein and a 3= quencher dye,
-carboxyltetramethyl-rhodamine. During the PCR reac-
ion, the AmpliTaq Gold DNA polymerase cleaves the
aqMan probe at the 5= end and separates the reporter dye
rom the quencher dye if the probe hybridizes to the target.
his cleavage results in the generation of a fluorescent signal
y the cleaved reporter dye, which is directly monitored by
he ABI Prism 7700 Detection System (Perkin-Elmer
orp., Foster City, California). The PCR conditions were
s follows: 45 cycles of denaturing at 95°C for 15 s and
rimer annealing/extension at 60°C for 60 s. The increase in
uorescent signal is proportional to the amount of specific
CR product generated. Primers and probes used for
CP-1, TGF-1, collagen type I and type III, GM-CSF,
nd GAPDH were as follows: MCP-1, forward primer:
=-CTCAGCCAGATGCAGTTAATGC-3=; reverse
rimer: 5=-TTCTCCAGCCGACTCATTGG-3=; Taq-
an probe: 5=-TCACCTGCTGCTACTCATTC-
CTGGC-3=; TGF-1, forward primer: 5=-GGCA-
CATCCATGACATGAA-3=; reverse primer: 5=-
AGGTGTTGAGCCCTTTCCA-3=; TaqMan probe:
=-CCTTCCTGCTCCTCATGGCCACC-3=; collagen
ype I, forward primer: 5=-CCAGTTCGAGTATGG-
AGCGA-3=; reverse primer: 5=-AGGTGATGTTCT-
GG-3=; TaqMan probe: 5=-CCTGCGCCTGATGTC-
ACCGA-3=; collagen type III, forward primer: 5=-
AGCTGGCCTTCCTCAGACTT-3=; reverse primer:
=-GCTGTTTTTGCAGTGGTATGTAATGT-3=;
aqMan probe: 5=-TTTCCAGCCGGGCCTCCCAG-
=; GM-CSF, forward primer: 5=-AGACCCGCCT-
AAGCTATACAA-3=; reverse primer: 5=-CTG-
TAGTGGCTGGCTATCATG-3=; TaqMan probe: 5=-
C T C A C C A A A C T C A A T G G C G C C T T G - 3 = ;
APDH, forward primer: 5=-AACTCCCTCAAGATT-
TCAGCAA-3=; reverse primer: 5=-GTGGTCAT-
AGCCCTTCCA-3=; TaqMan probe: 5=-CTG-
ACCACCAACTGCTTAGCCCC-3=. Data were
nalyzed using a Sequence Detector V1.6 program (Perkin-
lmer). The obtained CT (cycle number at which an
mplification threshold of detection is reached) values were
ormalized to rodent GAPDH expression by the Ct
ethod using trough sham levels as the calibrator value
10).
etermination of collagen concentration. Tissue ho-
ogenates were freeze-dried, weighed, and hydrolyzed in
N hydrochloric acid at 110°C for 24 h. Hydroxyproline
oncentration was measured spectrophotometrically (11). oollagen content was expressed in g/mg dry tissue weight
ssuming that collagen contains an average of 13.4% hy-
roxyproline. Assays were performed in duplicate.
mmunohistochemical evaluation. For immunohisto-
hemical evaluation, immunoperoxidase methods were em-
loyed. The excised heart was fixed with 10% paraformalde-
yde and embedded in paraffin according to routine
rocedures. The paraffin-embedded specimen was then cut
nto 6-m-thick sections and mounted on silanized slides.
ections were deparaffinized in xylene and dehydrated through
graded series of ethanol concentrations. Endogenous perox-
dase activity was blocked by 3% hydrogen peroxide for 5 min.
he sections were then incubated with a primary antibody,
D-1 (Serotec, Oxford, United Kingdom) at a dilution of 1:50
or 60 min at room temperature or MCP-1 (Cedarlane,
ntario, Canada) at a dilution of 1:100 for overnight at 4°C.
ext, the sections were treated with a biotinylated secondary
ntibody, anti-rabbit immunoglobulin G serum, for 10 min at
oom temperature using an LSAB2 kit (Dako, Carpinteria,
alifornia). After being washed for 10 min in phosphate-
uffered saline, the sections were incubated with streptavidin
eroxidase for 10 min. The sections were then washed again
or 10 min in phosphate-buffered saline and finally, colored
ith 3-amino-9-ethylcarbazole in N-dimethylformamidine.
erial sections were stained with hematoxylin-eosin.
uantitative histologic analysis. Stained sections were
hotographed with a Nikon digital camera (Nikon Corp.,
okyo, Japan) mounted on an Olympus microscope (Olym-
us Corp., Tokyo, Japan). Multiple digital images were
aken and stored for each sample. Staining was quantita-
ively analyzed using Scion image software (Scion Corp).
he number of macrophages was quantified by counting the
otal number of positively stained ED-1 cells in 20 grid
elds with a total area of 0.1 mm2. Four animals from each
roup were used for quantitation.
tatistical analyses. All values are presented as mean 
EM. One-way analysis of variance was performed for
tatistical comparisons, and if the analysis of variance results
ere significant, Scheffé’s post hoc test was performed.
wo-way repeated measures analysis of variance followed by
cheffé’s post hoc test was performed for analysis of the
ime-course variations. Significance was taken as p  0.05.
ll statistical analyses were performed using Statview 5.0
oftware (SAS Institute Inc., Cary, North Carolina).
ESULTS
ortality. Coronary artery ligation was performed in 105
ats. The perioperative mortality rate, within 24 h after the
peration, was 43% (45 rats). Finally, 60 rats were randomly
llocated to four groups as follows: Sham (13 rats),
ham/Ro (13 rats), MI/C (17 rats), and MI/Ro (17 rats).
he mortality of MI/Ro rats (8 deaths [47%]) was higher
han that of MI/C rats (4 deaths [24%]; p  0.05). In
ham-operated rats, romurtide administration had no effect
n mortality (Sham vs. Sham/Ro, 1 death [8%] vs. 1 death
[
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October 6, 2004:1510–20 Effect of GM-CSF Inducer on LV Remodeling8%], p  NS). No deaths involved cardiac rupture in all
roups.
hysiologic, hemodynamic, and echocardiographic pa-
ameters. The body weight of MI/Ro was not significantly
ncreased compared with those of the sham-operated con-
rol and MI/C groups. The heart weight to body weight
atio was similar among the four groups. The LV end-
iastolic pressure in MI/Ro was significantly higher than
hat in MI/C. The LV dP/dtmax in MI/Ro was signifi-
Table 1. Physiologic, Hemodynamic, and Echo
Sham
(n  6)
BW (g) 296  10
RV/BW (g/kg) 0.7 0.1
LV/BW (g/kg) 2.3 0.1
LVSP (mm Hg) 133  12
LVEDP (mm Hg) 5  1
LV dP/dtmax (mm Hg/s) 5,222  236
LV dP/dtmin (mm Hg/s) 5,422  215
LVEDD (mm) 5.5 0.4
LVESD (mm) 3.3 0.2
FS (%) 39  1
RWT 0.5  0.1
Values are mean  SEM. *p  0.05 versus Sham; †p  0.0
BW  body weight; FS  fractional shortening; LV  le
LVEDP  left ventricular end-diastolic pressure; LVESD
ventricular maximum rate of isovolumic pressure developme
pressure decay; LVSP  left ventricular systolic pressure; MI
treated with romurtide; RV right ventricular; RWT rela
Sham/Ro  Sham treated with romurtide.
igure 1. (A) Representative hematoxylin-eosin-stained midventricular
yocardial infarction treated with romurtide (MI/Ro) on day 14. (B) Expa
SEM. *p  0.05 versus MI/C.antly lower than that in MI/C. In sham-operated rats,
omurtide treatment had no effect on any of the hemody-
amic variables measured. The LVEDD and LVESD in
I/Ro were increased compared with those in MI/C. The
ractional shortening was significantly decreased in MI/Ro
ompared with MI/C. The RWT was similar among the
our groups (Table 1).
nfarct expansion on histologic analysis. Infarct expan-
ion was more apparent on histologic analysis in MI/Ro
iographic Parameters on Day 14
am/Ro
 5)
MI/C
(n  6)
MI/Ro
(n  5)
0  25 295  15 297 13
7  0.1 0.6  0.2 0.7 0.1
3  0.1 2.4  0.2 2.4 0.1
5  10 115  17 118 7
6  1 8  2 13 2*†‡
2  221 4,523  236*† 3,680  211*†‡
2  241 4,232  255*† 3,920  210*†
1  0.5 6.7  0.3* 8.0 0.4*†‡
9  0.3 5.2  0.2*† 6.4  0.3*†‡
7  1 24  6*† 18  3*†‡
4  0.1 0.4  0.1 0.3 0.1
us Sham/Ro; ‡p  0.05 versus MI/C.
ricular; LVEDD  left ventricular end-diastolic dimension;
ventricular end-systolic dimension; LV dP/dtmax  left
dP/dtmin  left ventricular minimum rate of isovolumic
myocardial infarction rats treated with saline; MI/Ro  MI
ll thickness; Sham sham-operated rats treated with saline;
sections of myocardial infarction rats treated with saline (MI/C) and
index on day 14 in MI/C and MI/Ro (n  4 per group). Values are meancard
Sh
(n
30
0.
2.
12
5,00
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6.
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0.
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Effect of GM-CSF Inducer on LV Remodeling October 6, 2004:1510–20ompared with MI/C (Fig. 1A). Expansion index in MI/Ro
as higher than that in MI/C (Fig. 1B).
hanges of peripheral leukocyte and monocyte count. Pe-
ipheral leukocyte counts in Sham/Ro and MI/Ro on days 2
nd 4 were significantly increased compared with those in
I/C (Fig. 2A). Peripheral monocyte count in MI/Ro on
ay 4 was significantly increased compared with that in
I/C (Fig. 2B).
nduction of local GM-CSF expression. The GM-CSF
igure 2. (A) Time course difference of peripheral leukocyte count among s
nfarction rats treated with saline (MI/C), and myocardial infarction treat
eripheral monocyte count among Sham, Sham/Ro, MI/C, and MI/Ro (n
ersus MI/C.RNA expression was increased 1.5-fold on day 3 (p  w.05) and 2-fold on day 7 (p  0.05) in the infarcted
yocardium of MI/C as compared with the LV of Sham.
he GM-CSF mRNA expression was increased 2.3-fold on
ay 3 (p  0.05) and 2-fold on day 7 (p  0.05) in the
nfarcted myocardium of MI/Ro as compared with MI/C.
owever, myocardial GM-CSF expression was not in-
reased by romurtide treatment in sham-operated rats. In
he non-infarcted sites of MI rats and in the myocardium of
ham rats, GM-CSF expression was not different during the
perated rats (Sham), Sham treated with romurtide (Sham/Ro), myocardial
th romurtide (MI/Ro) (n  4 per group). (B) Time course difference of
per group). Values are mean  SEM. *p  0.05 versus Sham; †p  0.05ham-o
ed wi
 4hole-examined period.
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October 6, 2004:1510–20 Effect of GM-CSF Inducer on LV Remodelingffect of GM-CSF inducer on MCP-1, TGF-1, colla-
en type I and type III expression. Figure 3 shows the
erial changes in myocardial protein expression of TGF-1.
he TGF-1 protein in the infarcted site on day 3 was
ecreased in MI/Ro compared with MI/C. However, the
ncrease of TGF-1 protein in MI/Ro was more prominent
n day 14 compared with that in MI/C. The TGF-1
rotein expression in the non-infarcted site was also in-
reased in MI/Ro compared with MI/C on day 14.
Serial changes in mRNA expression of these parameters
re shown in Figure 4. In the infarcted myocardium,
GF-1, collagen type I and type III mRNA expression on
ay 3 were decreased in MI/Ro compared with MI/C. The
CP-1 mRNA expression in the infarcted site on days 3
nd 7 was enhanced in MI/Ro compared with MI/C. The
GF-1, collagen type I and type III mRNA expression in
he infarcted and non-infarcted areas on day 14 was in-
reased by romurtide treatment.
nflammatory and fibrotic changes in histologic and
mmunohistologic analyses. On day 7, ED-1-positive
acrophages massively infiltrated the infarcted site in
igure 3. (A) Representative immunoblots showing transforming growth
and 14 among sham-operated rats (Sham), Sham treated with romurti
reated with romurtide (MI/Ro). (B) Quantified data of TGF-1 protein ex
nd MI/Ro (n  4 per group). Values are mean  SEM. *p  0.05 versI/Ro compared with MI/C. There were significantly rncreased numbers of ED-1-positive macrophages in the
nfarct zone (MI/Ro, 1,320 145 cells/mm2 vs. MI/C, 686
125 cells/mm2, p  0.05). The MCP-1-positive cells in
he infarcted site were also more prominent in MI/Ro than
n MI/C (MI/Ro, 420  151 cells/mm2 vs. MI/C, 235 
05 cells/mm2, p  0.05). These were not observed in the
yocardium of Sham and Sham/Ro (Fig. 5A). Mallory-
zan staining showed that fibrosis in the infarcted site was
ttenuated on day 7 but augmented on day 14 by romurtide
reatment (Fig. 5B).
ollagen concentration. In the infarcted region of
omurtide-treated MI rats, collagen content, assessed by
ydroxyproline concentration, was significantly lower on
ay 7 but higher on day 14 compared with MI/C. Collagen
ontent in the non-infarcted region of the romurtide-
reated MI rats was significantly increased on day 14
ompared with MI/C (Fig. 5C).
ISCUSSION
he GM-CSF induction by romurtide increased the pe-
(TGF)-1 protein level in the infarcted and non-infarcted sites on days
am/Ro), myocardial infarction rats treated with saline (MI/C), and MI
on in the infarcted and non-infarcted sites among Sham, Sham/Ro, MI/C,
am; †p  0.05 versus Sham/Ro; ‡p  0.05 versus MI/C.factor
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Effect of GM-CSF Inducer on LV Remodeling October 6, 2004:1510–20nd infiltration of ED-1-positive macrophages and reduced
he expression of TGF-1, collagen type I and type III
RNA in the infarcted myocardium during the early phase
f MI. Peripheral monocytosis, enhanced monocyte recruit-
ent into the infarcted myocardium, and delayed collagen
roduction by GM-CSF induction resulted in infarct ex-
ansion and aggravated LV remodeling.
Previous studies have demonstrated that excessive infil-
ration of leukocytes might be harmful for tissue repair. In
ecretory leukocyte protease inhibitor-deficient mice, exag-
erated leukocyte infiltration into wound sites was associ-
ted with impaired wound healing (12). Alternatively,
eduction of leukocyte infiltration in tumor necrosis factor
eceptor p55-deficient mice resulted in accelerated wound
ealing (13). Because GM-CSF delays macrophage and
igure 4. Effects of romurtide administration on monocyte chemoattractant
ollagen type III messenger ribonucleic acid (mRNA) expression in the infarcte
C) collagen type I, and (D) collagen type III mRNA expression in the infarct
II mRNA expression in the non-infarcted sites with real-time reverse transcri
reated with romurtide (Sham/Ro), myocardial infarction rats treated with sali
ean  SEM. *p  0.05 versus Sham; †p  0.05 versus Sham/Ro; ‡p  0onocyte apoptosis (14,15), it is possible that the enhancednd persistent infiltration of macrophages induced by ro-
urtide administration might cause delayed infarct healing.
In our study, romurtide treatment promoted ED-1-
ositive macrophages infiltration in the infarcted myocar-
ium of MI rats but not in the myocardium of sham-
perated rats, despite a similar increase in peripheral
onocyte count. Many studies have demonstrated that
M-CSF promotes the infiltration of monocytes and mac-
ophages after tissue injury. However, GM-CSF itself has
o effect on monocyte transmigration or adhesion to cul-
ured endothelial cells (14). Under the influence of che-
oattractants such as MCP-1 that are produced in response
o injury, GM-CSF promotes the effective recruitment of
irculating monocytes to local inflammatory sites by attach-
ent to the endothelium (16,17).
n (MCP)-1, transforming growth factor (TGF)-1, and collagen type I and
non-infarcted sites. Quantitative analyses showing (A) MCP-1, (B) TGF-1,
es and (E) MCP-1, (F) TGF-1, (G) collagen type I, and (H) collagen type
polymerase chain reaction analyses among sham-operated rats (Sham), Sham
I/C), and MI treated with romurtide (MI/Ro) (n 5 per group). Values are
rsus MI/C. Continued on next page.protei
d and
ed sit
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f collagen accumulation, which was induced by osteopon-
in knock-out, caused excessive infarct expansion during the
nfarct healing process (18). In human experimental
ounds, GM-CSF inhibited collagen deposition, possibly
hrough prolonged monocyte infiltration (19). In the
resent study, romurtide induced peripheral monocytosis,
CP-1 upregulation, and ED-1-positive macrophage in-
ltration, suggesting excessive inflammation in local in-
arcted sites. Additionally, collagen production in the in-
arcted site was inhibited by romurtide administration
uring the early phase of MI. These results indicate that
rolonged inflammation might delay collagen production,
esulting in infarct expansion. Although an earlier study
emonstrated that collagen type I and type III mRNA
xpression levels reached a peak at seven days after MI in
he rat heart (20), the mRNA levels on day 14 were even
igher than those on day 7 in romurtide-treated MI rats in
ur study.
Degradation of extracellular collagen matrix (ECM) also
lays an important role in post-MI remodeling. Several
Figure 4roteinases, including matrix metalloproteinases, plasmin, Tnd cathepsin are expressed in the infiltrating inflammatory
ells in the infarcted area (21,22). These enzymes are known
o be related to the occurrence of cardiac rupture and LV
emodeling. Previous studies showed that the incidence of
ardiac rupture in a mouse MI model was reduced by
nock-out of matrix metalloproteinase-9, urokinase-type
lasminogen activator, or plasminogen in association with
ess leukocyte infiltration into the infarcted area (23,24). In
ur study, on day 7, collagen content was lower and the
nfiltration of ED-1-positive macrophages was more prom-
nent in the infarcted area of romurtide-treated MI rats than
hat of MI-control rats. These findings demonstrated that
xcessive infiltration of inflammatory cells might cause an
mbalance of ECM synthesis/degradation, resulting in ad-
erse post-MI remodeling.
Myofibroblasts are important for fibrogenesis at sites of
emodeling after MI. Transforming growth factor-1 is a
ajor fibrogenic cytokine and contributes to differentiation
f fibroblasts into myofibroblasts. Myofibroblasts are co-
ocalized with accumulated collagen and are responsible for
ncreased expression of collagen type I and type III. The
inued.GF-1 in the infarcted myocardium is primarily produced
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lasts in the fibrogenic phase of healing (25). It is possible
hat prolonged activation of macrophages by GM-CSF
nduction might suppress collagen production by delaying
yofibroblast proliferation and migration.
In non-infarcted sites, excessive collagen accumulation is
nown to increase myocardial stiffness and to worsen
igure 5. (A) Results of immunohistochemical staining of the infarcted si
ith romurtide (MI/Ro), and of the left ventricle (LV) of the sham-operat
f monoclonal anti-ED-1 and anti-monocyte chemoattractant protein-1 (an
nd MCP-1-positive cells are stained brown. (B) Mallory-Azan staining in
ham animals (Sham and Sham/Ro) on days 7 and 14 (magnification 40
on-infarcted sites of MI/C and MI/Ro and in the LV of Sham and Sham
0.05 versus Sham/Ro; ‡p  0.05 versus MI/C.ontractile function, contributing to the progression of most-MI remodeling (26). The increased LVEDD and
levated LV end-diastolic pressure in GM-CSF inducer-
reated rats may be caused not only by reduced collagen
eposition in the infarcted sites but also by increased
ollagen deposition in the non-infarcted sites. Delayed
nfarct healing and early LV remodeling induced by GM-
SF might increase wall stress and subsequently promote
the myocardial infarction rats treated with saline (MI/C) and MI treated
s (Sham) and Sham treated with romurtide (Sham/Ro) on day 7 with use
CP-1) antibodies (magnification 400). The ED-1-positive macrophages
nfarcted sites of the MI animals (MI/C and MI/Ro) and in the LV of the
Fibrous tissue appears blue. (C) Collagen content in the infarcted and
(n  4 per group). Values are mean  SEM. *p  0.05 versus Sham; †ptes of
ed rat
ti-M
the i
0).
/Royocardial remodeling in non-infarcted sites. The GM-
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ccording to different locations and timing.
We have reported that peak serum C-reactive protein
evel or peak peripheral monocyte count could be a predictor
f adverse LV remodeling and poor long-term outcome
fter MI. These indices, determined two to three days after
I, could predict long-term LV remodeling, suggesting
hat an excessive inflammatory response during the early
hase of MI could affect the infarct healing process and
entricular structural remodeling (4,27). In our study, ro-
urtide was administered for seven consecutive days after
oronary ligation. During this phase, the infarcted myocar-
ium might be most vulnerable to various stimuli including
echanical stress, inflammatory cytokines, and neurohor-
onal factors. Interventions in the infarct healing process
uring the early phase of MI might have a great impact on
ong-term LV remodeling. It has been believed that the use
f corticosteroids after MI has a deleterious effect on the
nfarct healing process and increases the incidence of cardiac
upture or infarct expansion (28). However, a recent meta-
nalysis demonstrated a possible mortality benefit of admin-
stration of corticosteroids for acute MI (29). Inhibition of
he excessive inflammatory response, especially monocyte
nd macrophage activation, during the early phase of MI
ay be beneficial to prevent LV remodeling.
tudy limitations. First, we did not examine the direct
ffect of GM-CSF on cardiomyocytes. Because GM-CSF
dministration in cancer patients reduced cardiac contrac-
ility, GM-CSF itself might directly influence the infarcted
eart (30). Second, GM-CSF promoted collateral growth in
atients with chronic coronary artery disease (31). Collateral
rowth, caused by GM-CSF induction, may influence the
nfarct healing process. However, the association between
ollateral growth and LV remodeling was not clarified in
ur setting. Third, GM-CSF induced the mobilization of
one marrow-derived endothelial progenitor cells for neo-
ascularization (32). Although regeneration therapy for
njured myocardium, consisting of myocytes, vessels, and
CM, could be effective for preventing post-MI remodel-
ng, the effect of GM-CSF induction on regeneration of
njured myocardium was not examined in this study. The
ossibility of GM-CSF for myocardial regeneration will be
urther investigated.
onclusions. The GM-CSF induction by romurtide re-
ulted in infarct expansion and aggravated LV remodeling.
he acute inflammatory response during the early phase of
I could be a potential target for the treatment of patients
ith MI.
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